Cytokinetics reported $1.27B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
Acadia Pharmaceuticals USD 73.85M 23.06M Jun/2026
Amgen USD 57.3B 19M Jun/2026
Arca Biopharma USD 0 0 Mar/2025
Bayer EUR 36.45B 2.93B Dec/2025
Biogen USD 7.69B 398.3M Sep/2026
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cytokinetics USD 1.27B 18.17M Jun/2026
Eisai JPY 254.94B 68.86B Sep/2026
Eli Lilly USD 54.91B 11.54B Jun/2026
Exelixis USD 162.2M 3.73M Sep/2026
Geron USD 122.14M 78K Jun/2026
Halozyme Therapeutics USD 2.15B 2.02M Jun/2026
Ionis Pharmaceuticals USD 1.77B 141M Sep/2026
Ligand Pharmaceuticals USD 1.13B 679.48M Jun/2026
Merck USD 53.91B 4.79B Jun/2026
Novartis USD 49.01B 2.02B Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Regeneron Pharmaceuticals USD 2.71B 400K Jun/2026
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 23.58B 3.56B Jun/2026